Skip to main content

Share story

AI

From asking to doing: How the world is putting ChatGPT to work

OpenAI published country-by-country data on August 6 showing how more than 1 billion people use ChatGPT, revealing a shift from asking questions to completing tasks. The company said the data reflects messages sent within ChatGPT Free, Go, Plus, and Pro accounts managed by individuals rather than organizations. At work, people are more than twice as likely to use ChatGPT to complete tasks such as writing, coding, and analysis than they are outside work. Outside of work, seeking information remains the largest category of use. The adoption gap is closing as countries in Latin America, Africa, and Oceania catch up to early adopters, with Peru, Uruguay, and Costa Rica rising the most in global per-capita rankings during the second quarter of 2026. Multimedia use is the fastest-growing category globally, accounting for 7.8% of messages and more than one in ten in Brazil and Colombia following the release of ChatGPT Images 2.0 in April 2026. Usage among people over 35 is rising in nearly every country, with the share of messages increasing by more than 10 percentage points in France and Czechia over the past year.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from OpenAI and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...